BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31628883)

  • 1. Complications of herpes zoster in children.
    Kanamori K; Shoji K; Kinoshita N; Ishiguro A; Miyairi I
    Pediatr Int; 2019 Dec; 61(12):1216-1220. PubMed ID: 31628883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster in immunocompetent and immunocompromised Japanese children.
    Takayama N; Yamada H; Kaku H; Minamitani M
    Pediatr Int; 2000 Jun; 42(3):275-9. PubMed ID: 10881585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of children hospitalized with herpes zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991-2005.
    Wootton SH; Law B; Tan B; Mozel M; Scheifele DW; Halperin S;
    Pediatr Infect Dis J; 2008 Feb; 27(2):112-8. PubMed ID: 18174867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients.
    Bieńkowski C; Talarek E; Pokorska-Śpiewak M
    J Paediatr Child Health; 2023 Oct; 59(10):1112-1114. PubMed ID: 37357994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Manifestations of Herpes Zoster Associated with Complications in Children.
    Kang DH; Kwak BO; Park AY; Kim HW
    Children (Basel); 2021 Sep; 8(10):. PubMed ID: 34682110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir.
    Kuchar E; Szenborn L; Lis I; Jaroszewska A; Czeladzka J
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):394-7. PubMed ID: 27347778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster guideline of the German Dermatology Society (DDG).
    Gross G; Schöfer H; Wassilew S; Friese K; Timm A; Guthoff R; Pau HW; Malin JP; Wutzler P; Doerr HW
    J Clin Virol; 2003 Apr; 26(3):277-89; discussion 291-3. PubMed ID: 12637076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.
    Yawn BP; Saddier P; Wollan PC; St Sauver JL; Kurland MJ; Sy LS
    Mayo Clin Proc; 2007 Nov; 82(11):1341-9. PubMed ID: 17976353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of herpes zoster and its complications in Germany, 2005-2009.
    Hillebrand K; Bricout H; Schulze-Rath R; Schink T; Garbe E
    J Infect; 2015 Feb; 70(2):178-86. PubMed ID: 25230396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular findings in Japanese patients with varicella-zoster virus infection.
    Yoshida M; Hayasaka S; Yamada T; Yanagisawa S; Hayasaka Y; Nakamura N; Mihara M
    Ophthalmologica; 2005; 219(5):272-5. PubMed ID: 16123552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster and meningitis in an immunocompetent child: a case report.
    Yasuda R; Minami K; Ogawa A; Okada H; Terakawa R; Koike Y; Ogura S; Takeuchi K; Higuchi T
    J Med Case Rep; 2019 Jun; 13(1):182. PubMed ID: 31200772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
    Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
    Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
    Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
    J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in pediatric Herpes zoster hospitalization rate after Varicella immunization.
    Critselis E; Theodoridou K; Alexopoulou Z; Theodoridou M; Papaevangelou V
    Pediatr Int; 2016 Jun; 58(6):534-6. PubMed ID: 27322864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.
    Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V
    BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS
    Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head.
    Lee HL; Yeo M; Choi GH; Lee JY; Kim JS; Shin DI; Lee SS; Lee SH
    Clin Neurol Neurosurg; 2017 Jan; 152():90-94. PubMed ID: 27978460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with Brivudine in Immunocompromised Pediatric Patients with Herpes Zoster.
    Vogel C; Wetzel L; Wutzler P; Gruhn B
    Chemotherapy; 2023; 68(4):222-227. PubMed ID: 37231819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.